	Actif À Court Terme		Date
Agilent	USD 4.59B	341M	2025-09
Align Technology	USD 2.62B	82.47M	2025-12
Bio Techne	USD 637.43M	27.92M	2025-12
BioMarin Pharmaceutical	USD 3.85B	49.21M	2025-09
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Bruker	USD 2.21B	138.1M	2025-12
Charles River Laboratories	USD 1.45B	85.06M	2025-12
Danaher	USD 12.76B	3.15B	2025-12
Dentsply International	USD 2.07B	106M	2025-09
Exact Sciences	USD 1.56B	34.88M	2025-12
General Electric Aerospace	USD 40.6B	522M	2025-12
Henry Schein	USD 4.4B	152M	2025-09
Illumina	USD 3.29B	493M	2025-12
IQVIA Holdings	USD 6.25B	270M	2025-12
Mettler Toledo International	USD 1.36B	81.46M	2025-12
Myriad Genetics	USD 344.8M	60.5M	2025-09
OraSure Technologies	USD 283.01M	18.43M	2025-09
Pacific Biosciences Of California	USD 394.24M	19.16M	2025-09
Pfizer	USD 46.92B	3.22B	2025-09
Repligen	USD 1.1B	39.62M	2025-09
Revvity	USD 2.24B	95.96M	2025-12
Standard Biotools	USD 472.44M	33.6M	2025-09
Thermo Fisher Scientific	USD 28.71B	6.41B	2025-12
Waters	USD 1.99B	69.86M	2025-12
West Pharmaceutical Services	USD 1.98B	154.9M	2025-12

Repligen Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.